Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial

RCT (n=1,027) found no significant reduction in clinical events (non-fatal MI, revascularisation, stroke, all-cause death, heart failure hospitalisation) after 2 years with 1.8 g n-3 polyunsaturated fatty acidsdaily vs placebo (21.4% vs 20.0%; p=0.60).

Source:

Circulation